PIK3CA and ovarian cancer: To evaluate the efficacy of PI3K inhibitor BKM120 in ovarian cancer cells, we chose four PIK3CA mutant ovarian cancer cell lines (SKOV3, IGROV1, HEYA8, and EFO27) for further examination.